Bile acids regulate RANTES gene expression through its cognate NF-κB binding sites

Biochemical and Biophysical Research Communications

Volumn 288, Issue 5, 2001, Pages 1095-1101

  Hirano, Fuminori ^a   Kobayashi, Atsushi ^a   Hirano, Yoshiko ^a   Nomura, Yoshinobu ^a   Fukawa, Etsushi ^a   Makino, Isao ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Bile acid; Chenodeoxycholic acid; NF B; RANTES

Indexed keywords

BILE ACID; CHENODEOXYCHOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; RANTES;

ARTICLE; BILIARY CIRRHOSIS; BINDING SITE; CELL MIGRATION; CONTROLLED STUDY; DNA BINDING; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYDROPHOBICITY; INFLAMMATORY CELL; MEMORY CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION;

EID: 0035900599     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5893     Document Type: Article

References (43)

1. Primary biliary cirrhosis
2. Primary biliary cirrhosis: Identification of two major M2 mitochondrial autoantigens
3. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis
4. Immunophenotyping of lymphocytes in liver tissue of patients with chronic liver diseases by flow cytometry
5. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: Increase in activated T and natural killer cells and recruitment of primed memory T cells
6. CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis
7. Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis
8. Primary biliary cirrhosis: Clarifying the issues
9. Pruritus associated with cholestasis. A review of pathogenesis and management
10. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes
11. Ursodeoxycholic acid for the treatment of home parenteral nutrition-associated cholestasis. A case report
12. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: Effects on bile formation and liver plasma membranes
13. Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: A 30-month pilot study
14. Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial
15. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
16. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
17. Hepatocellular and biliary expression of HLA antigens in primary biliary cirrhosis before and after ursodeoxycholic acid therapy
18. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
19. Chemokines and T lymphocytes: More than an attraction
20. Biology of the RANTES/SIS cytokine family
21. Chemokine levels in human liver homogenates: Associations between GROα and histopathological evidence of alcoholic hepatitis
22. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma
23. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions
24. Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatography-mass spectrometry: Effect of ursodeoxycholic acid treatment
25. Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis
26. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration
27. Kinetics of hepatic bile acid handling in cholestatic liver disease: Effect of ursodeoxycholic acid
28. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
29. Thrombin stimulates cell proliferation in human fibroblast-like synoviocytes in nuclear factor-κB activation and protein kinase C mediated pathway
30. Induction of the transcription factor AP-1 in cultured human colon adenocarcinoma cells following exposure to bile acids
31. Genomic organization and transcriptional regulation of the RANTES chemokine gene
32. Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes
33. Chenodeoxycholic acid-dependent induction of major histocompatibility complex class I mRNA expression in a human hepatoma cell line
34. Regulation of the major histocompatibility complex class I mRNA expression by bile acids in cultured human hepatoma cells
35. Activation of IκB kinaseβ by protein kinase C isoforms
36. Role of the protein kinase C λ/ι isoform in nuclear factor-κB activation by interleukin-1β or tumor necrosis factor-α: Cell type specificities
37. Activation of mast cells by bile acids
38. Transcriptional regulation of cholesterol 7 α-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytes
39. Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells
40. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR
41. Identification of a nuclear receptor for bile acids
42. Bile acids: Natural ligands for an orphan nuclear receptor
43. Identification of a nuclear receptor that is activated by farnesol metabolites